Welcome to the international HTA database

Showing [16495 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cleaning wipes for prevention of C. difficile infection in the hospital setting: clinical effectiveness
2014	NIHR Health Technology Assessment programme	Assessing the risk of self-harm in an adult offender population: an incidence cohort study
2014	HAYES, Inc.	Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
2014	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal bacteriotherapy for adult patients with recurrent clostridium difficile infection: update of clinical, cost-effectiveness, and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for cancer screening and treatment
2014	HAYES, Inc.	Virtual bronchoscopic navigation for evaluation of peripheral pulmonary lesions
2014	NIHR Health Technology Assessment programme	Interventions for adult eustachian tube dysfunction: a systematic review
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antibacterial sutures for wound closure after surgery: update on clinical effectiveness and guidelines for use
2014	Agency for Healthcare Research and Quality (AHRQ)	Therapies for clinically localized prostate cancer: update of a 2008 systematic review
2014	HAYES, Inc.	Agento I.C. silver-coated endotracheal tube (C.R. Bard Inc.) for the prevention of ventilator-associated pneumonia (VAP)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Indacaterol/glycopyrronium (Ultibro® Breezhaler®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Population-based colorectal cancer screening: guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Radiotherapy treatments for head and neck cancer update
2014	HAYES, Inc.	Autologous bone marrow-derived mesenchymal stem cell therapy for treatment of nonunion of the lower extremity
2014	NIHR Public Health Research (PHR) programme	Putting Life in Years (PLINY): a randomised controlled trial and mixed-methods process evaluation of a telephone friendship intervention to improve mental well-being in independently living older people
2014	NIHR Health Technology Assessment programme	Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Extracorporeal photopheresis following bone marrow transplant: clinical effectiveness
2014	HAYES, Inc.	BD veritor system for rapid detection of flu A+B (Becton, Dickinson and Company) for detection of Influenza types A and B viral antigens
2014	NIHR Public Health Research (PHR) programme	A pilot feasibility cluster randomised controlled trial of screening and brief alcohol intervention to prevent hazardous drinking in young people aged 14 15 years in a high school setting (SIPS JR-HIGH)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tocilizumab (RoActemra®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Post-surgical surveillance for surgical site infections: guidelines
2014	NIHR Health Services and Delivery Research programme	Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study
2014	HAYES, Inc.	CellSearch circulating tumor cell (CTC) kit (Janssen Diagnostics LLC) for monitoring metastatic breast cancer
2014	NIHR Public Health Research (PHR) programme	A pragmatic evaluation of a family-based intervention for childhood overweight and obesity
2014	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of cholecystectomy versus observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2014	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Oral nutrition intake for the prevention of falls in older adults: clinical effectiveness and guidelines
2014	NIHR Health Services and Delivery Research programme	A qualitative study of the knowledge-brokering role of middle-level managers in service innovation: managing the translation gap in patient safety for older persons care
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: OHTAC recommendation
2014	HAYES, Inc.	ChemoFx assay (Precision Therapeutics Inc.) for prediction of response to chemotherapy for ovarian cancer
2014	NIHR Public Health Research (PHR) programme	Does the Royal Horticultural Society Campaign for School Gardening increase intake of fruit and vegetables in children? Results from two randomised controlled trials
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2014	NIHR Health Services and Delivery Research programme	A formative evaluation of Collaboration for Leadership in Applied Health Research and Care (CLAHRC): institutional entrepreneurship for service innovation
2014	Health Quality Ontario (HQO)	End-of-life health care in Ontario: OHTAC recommendation
2014	HAYES, Inc.	Collagen meniscus implant (CMI, Menaflex; Ivy Sports Medicine LLC) for treatment of meniscal tears
2014	NIHR Public Health Research (PHR) programme	Outreach programmes for health improvement of Traveller Communities: a synthesis of evidence
2014	Medical Advisory Secretariat (MAS)	Multiple intravenous infusions
2014	NIHR Health Technology Assessment programme	Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tools assessing patient-reported outcome measures in cancer patients: accuracy and guidelines
2014	NIHR Health Services and Delivery Research programme	Development of methodological guidance, publication standards and training materials for realist and meta-narrative reviews: the RAMESES (Realist And Meta-narrative Evidence Syntheses - Evolving Standards) project
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: an evidence update
2014	HAYES, Inc.	Computed tomography-guided percutaneous microwave ablation for lung nodules
2013	HAYES, Inc.	CyberKnife robotic radiosurgery system (Accuray Inc.) for treatment of prostate cancer
2013	HAYES, Inc.	Impella Recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock
2013	HAYES, Inc.	Lokomat (Hocoma AG) Driven Gait Orthosis (DGO) for use in children with cerebral palsy
2013	Health Quality Ontario (HQO)	Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation
2013	HAYES, Inc.	Impella recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for patients undergoing high-risk percutaneous coronary intervention (PCI)
2013	HAYES, Inc.	Intratympanic steroid injection for ménière's disease
2013	HAYES, Inc.	Magnetic Resonance Guided Focused Ultrasound Therapy (MRgFUS) (ExAblate; InSightec Ltd.) for palliation of painful bone metastases
2013	Health Quality Ontario (HQO)	Transient ischemic attack: where can patients receive optimal care? A rapid review
2013	NIHR Health Technology Assessment programme	Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness
2013	HAYES, Inc.	iStent trabecular micro-bypass stent (Glaukos Corp.) for treatment of primary open-angle glaucoma
2013	HAYES, Inc.	Osteochondral allograft transplantation for articular disorders of the ankle
2013	HAYES, Inc.	Microsurgery for primary prevention of lymphedema following surgery for breast cancer
2013	Agency for Healthcare Research and Quality (AHRQ)	Skin substitutes for treating chronic wounds
2013	Health Quality Ontario (HQO)	Vasodilators for inhospital heart failure management: a rapid review
2013	NIHR Health Technology Assessment programme	Evaluation of mammographic surveillance services inwomen aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study
2013	NIHR Health Technology Assessment programme	Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial
2013	HAYES, Inc.	MindStreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S. Clinical Edition) for assessing mild cognitive impairment
2013	HAYES, Inc.	Preadmission patient bathing with 2% chlorhexidine gluconate cloths (Sage Products Inc.) for prevention of surgical site infection
2013	HAYES, Inc.	Microsurgical treatment of lymphedema following breast cancer surgery
2013	Health Quality Ontario (HQO)	Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2013	HAYES, Inc.	Preoperative whole-body bathing with chlorhexidine gluconate 4% for prevention of surgical site infection
2013	HAYES, Inc.	Presurgical nasoalveolar molding for cleft lip and palate repair in children
2013	HAYES, Inc.	Postoperative bracing after Anterior Cruciate Ligament (ACL) repair
2013	Health Quality Ontario (HQO)	Early mobilization and ambulation in hospitalized heart failure patients:a rapid review
2013	HAYES, Inc.	Pudendal nerve block for treatment of pudendal neuralgia
2013	HAYES, Inc.	Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea
2013	Health Quality Ontario (HQO)	Early mobilization and ambulation in hospitalized heart failure patients: a rapid review
2013	HAYES, Inc.	Pudendal nerve decompression surgery for treatment of pudendal neuralgia
2013	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for catheter ablation of atrial fibrillation and other arrhythmias
2013	Health Quality Ontario (HQO)	Coronary revascularization in ischemic heart failure patients: a rapid review
2013	NIHR Health Technology Assessment programme	Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling
2013	HAYES, Inc.	Radioiodinated metaiodobenzylguanidine (131I-MIBG) targeted radiation therapy for refractory or relapsed neuroblastoma
2013	HAYES, Inc.	Transabdominal Cervical Cerclage (TAC) for the prevention of miscarriage
2013	Health Quality Ontario (HQO)	The effectiveness of statins for primary prevention: a rapid review
2013	HAYES, Inc.	Tai chi for improving balance and function in patients with parkinson's disease
2013	HAYES, Inc.	Use of negative-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	Agency for Healthcare Research and Quality (AHRQ)	Use of natriuretic peptide measurement in the management of heart failure
2013	Health Quality Ontario (HQO)	Effectiveness of increased intensity of rehabilitation in post-stroke patients: a rapid review
2013	NIHR Health Technology Assessment programme	The diagnostic utility and cost-effectiveness of selective nerve root blocks in patients considered for lumbar decompression surgery: a systematic review and economic model
2013	HAYES, Inc.	Use of anti-infliximab antibody levels to monitor infliximab treatment in patients with inflammatory bowel disease (IBD)
2013	HAYES, Inc.	Use of neutral-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	Health Quality Ontario (HQO)	Optimal onset-to-admission interval for inpatient stroke rehabilitation: a rapid review
2013	HAYES, Inc.	VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2013	HAYES, Inc.	Use of positive-displacement needleless connectors and rates of catheter-related bloodstream infections
2013	Agency for Healthcare Research and Quality (AHRQ)	Chronic venous ulcers: a comparative effectiveness review of treatment modalities
2013	Health Quality Ontario (HQO)	Optimal timing to begin an active rehabilitation program after a hip fracture: a rapid review
2013	NIHR Health Technology Assessment programme	Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Insulin glargine (Lantus®) 100 units/ml solution for injection
2013	NIHR Health Technology Assessment programme	Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours
2013	Health Quality Ontario (HQO)	Nerve blocks for pain management in patients with hip fractures: a rapid review
2013	NIHR Health Technology Assessment programme	The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	C1 inhibitor (Cinryze®) 500 units powder and solvent for solution for injection
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Brentuximab vedotin (Adcetris) for Hodgkin lymphoma